Last updated on February 2019

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

Brief description of study

The purpose of this study is to assess the safety and efficacy of galcanezumab in people with treatment-resistant episodic or chronic migraine.

Clinical Study Identifier: NCT03559257

Contact Investigators or Research Sites near you

Start Over

Hikaru Mizobuchi

Medical corporation Shinmatsudakai Atago Hospital
Kochi-Shi, Japan

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.